| Financial Year |
March 31 2023 |
| Monetary Funds |
1,572,678,555.13 |
| Held-for-trading Financial Assets |
1,004,437,666.66 |
| Notes Receivable |
-- |
| Accounts Receivable |
4,259,969.62 |
| Advances to Suppliers |
7,671,998.65 |
| Other Receivables |
14,686,139.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,511,265.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,614,289.85 |
| Total Current Assets |
2,646,859,884.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,774,591,446.60 |
| Investment Properties |
-- |
| Fixed Assetes |
2,401,497,544.11 |
| Under-construction Projects |
439,411,689.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
996,825,730.14 |
| R&D expenses |
-- |
| Goodwill |
1,573,240.33 |
| Long-Term Deferred and Prepaid Expenses |
608,095,293.21 |
| Deferred Income Tax Assets |
32,896,581.42 |
| Other Non-Current Assets |
2,139,205.62 |
| Sub-Total of Non-Current Assets |
6,785,992,506.48 |
| Total Assets |
9,432,852,391.19 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
280,507,167.97 |
| Accounts Received In Advance |
16,743,414.82 |
| Employee Compensation Payable |
4,966,621.95 |
| Taxes Payable |
24,809,739.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
49,851,526.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
291,259,822.49 |
| Other Current Liabilities |
6,471,885.49 |
| Sub-Total of Current Liabilities |
801,204,014.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,109,416.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
725,360,260.80 |
| Total Liabilities |
1,526,564,275.20 |
| Paid-In Capital(Or Share Stock) |
2,614,694,040.00 |
| Capital Surplus |
1,231,921,598.20 |
| Surplus Reserve |
568,611,841.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,292,205,955.38 |
| Minority Stockholder's Interest |
281,565,673.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,624,722,442.79 |
| Owner's Equity（Stockholder's Equity） |
7,906,288,115.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,432,852,391.19 |
